In vitro assay based on cAMP levels modulated by Gi-coupled receptors
WO2005002560A1
Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression
FR2855970A1
Treatment of depression without significant side-effects, comprises administration of alverine or its metabolites, showing strong affinity for sigma-1, sigma-2 and 5-HT1a receptors
FR2843750A1
COMPOUNDS DERIVED FROM ARYLCARBAMATES, PREPARATION AND USES
FR2821356A1
NOVEL ARYLCARBAMATE AND ARYLUREES DERIVATIVES, PREPARATIONS AND USES
FR2792936A1
OXA COMBINATORIAL BANKS, PREPARATION AND UTILIZATION.
EP0918296A1
Method of virtual retrieval of analogs of lead compounds by constituting potential libraries
EP0905512A1
Method of identification of leads or active compounds
